HIF1A and cancer: Thymoquinone being potent anticancer agent significantly lowers the hypoxia‐inducible factor‐1α (HIF‐1α) expression, inhibits interaction between HSP90 and HIF‐1α, and boosts HIF‐1α protein degradation in hypoxic cancer cells.